In a cohort study reported in JAMA Internal Medicine, Reimers et al found that aspirin use was associated with a significant 47% reduction in mortality risk after diagnosis of colon cancer expressing HLA class I antigen.
Read more →Melatonin, sleep disturbance and cancer risk The pineal hormone melatonin is involved in the circadian regulation and facilitation of sleep, the inhibition of cancer development and growth, and the enhancement of immune function. Individuals, such as night shift workers, who are exposed to light at night on a regular basis experience biological rhythm (i.e., circadian) disruption including
Read more →Treating Prostate Cancer with Immune Therapy, Using the Gorter Model Authors: Robert Gorter, MD, PhD, and Erik Peper, PhD „I had a primary tumor. It is no long there. You can feel it when a large tumor in the prostate is gone and you can also see it on an ultrasound. Now my PSA is
Read more →Progress occurs by leaps and bounds not by incremental change. Author Robert W. Gorter, MD, PhD. Progress occurs by leaps and bounds not by incremental change Author: Robert W. Gorter, MD, PhD. The incremental improvement of standard therapies through improved surgical techniques, radiation, chemotherapy or medications that can be patented or slight changes in treatment
Read more →CVax®-brain shows survival for patients with brain cancer Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival Long-Term Follow-Up of DCVax®-Treated Brain Cancer Patients Shows 33% of Patients Reached 4-Year Survival and 27% Have Reached or Exceeded 6-Year Survival. BETHESDA, Md.,
Read more →
Deutsch
Nederlands
Turkish
Russian
Italiano
Français
Português
العربية